Literature DB >> 2642173

Antibody-dependent cellular cytotoxicity by polymorphonuclear leucocytes in patients with AIDS and AIDS-related complex.

T J Kinne1, S Gupta.   

Abstract

Polymorphonuclear leucocytes (PMN) play an important role in host defense against bacterial and certain fungal infections. Furthermore, PMN are effectors in antibody-dependent cellular cytotoxicity (ADCC) against a variety of tumor and non-tumor target cells. In this study we examine the PMN-mediated ADCC in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC), using chicken red blood cells (CRBC) in the presence of anti-CRBC antibody as targets. Ten subjects each with AIDS, ARC and healthy controls were evaluated. Among AIDS patients one had Kaposi's sarcoma (KS) and 9 had opportunistic infection(s). A significantly decreased (p less than 0.005) ADCC was observed in both patients with AIDS and ARC. Although ADCC tended to be lower in ARC than in AIDS, however the difference between AIDS and ARC was not significant (p greater than 0.5). We suggest that the deficient PMN-mediated ADCC in human immunodeficiency virus (HIV) infection might play a role in increased predisposition to bacterial and certain opportunistic infections and perhaps in the spread of HIV infection.

Entities:  

Mesh:

Year:  1989        PMID: 2642173

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  3 in total

1.  Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome.

Authors:  D L Pitrak; H C Tsai; K M Mullane; S H Sutton; P Stevens
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

Review 2.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

Review 3.  Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1.

Authors:  George K Lewis; Margaret E Ackerman; Gabriella Scarlatti; Christiane Moog; Marjorie Robert-Guroff; Stephen J Kent; Julie Overbaugh; R Keith Reeves; Guido Ferrari; Bargavi Thyagarajan
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.